COVID-19 vaccines: A race against time.
作者信息
Peiffer-Smadja Nathan, Rozencwajg Sacha, Kherabi Yousra, Yazdanpanah Yazdan, Montravers Philippe
机构信息
Infectious Diseases Department, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France; Université de Paris, INSERM, IAME, F-75006 Paris, France; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, United Kingdom.
Department of Anaesthesiology and Critical Care Medicine, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris, France; Université de Paris, Paris, France.
出版信息
Anaesth Crit Care Pain Med. 2021 Apr;40(2):100848. doi: 10.1016/j.accpm.2021.100848. Epub 2021 Mar 24.
Abstract
摘要
相似文献
1
COVID-19 vaccines: A race against time.新冠疫苗：与时间赛跑
Anaesth Crit Care Pain Med. 2021 Apr;40(2):100848. doi: 10.1016/j.accpm.2021.100848. Epub 2021 Mar 24.
2
COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.COVID-19 疫苗：紧跟 SARS-CoV-2 变异株。
Cell. 2021 Sep 30;184(20):5077-5081. doi: 10.1016/j.cell.2021.09.010. Epub 2021 Sep 17.
3
The overlooked superpower of mRNA vaccines.mRNA疫苗被忽视的强大力量。
Science. 2021 Jul 30;373(6554):479. doi: 10.1126/science.373.6554.479.
4
The long road.漫长的道路。
Science. 2021 Feb 19;371(6531):768-772. doi: 10.1126/science.371.6531.768.
5
Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.新冠病毒变异株B.1.429和B.1.351的中和作用
N Engl J Med. 2021 Jun 17;384(24):2352-2354. doi: 10.1056/NEJMc2103740. Epub 2021 Apr 7.
6
Could new COVID variants undermine vaccines? Labs scramble to find out.新冠病毒新变种会削弱疫苗效力吗？各实验室竞相展开研究。
Nature. 2021 Jan;589(7841):177-178. doi: 10.1038/d41586-021-00031-0.
7
Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.mRNA-1273 对 SARS-CoV-2 变异株的血清中和活性。
J Virol. 2021 Nov 9;95(23):e0131321. doi: 10.1128/JVI.01313-21. Epub 2021 Sep 22.
8
How can countries stretch COVID vaccine supplies? Scientists are divided over dosing strategies.各国如何延长新冠疫苗供应？科学家们在给药策略上存在分歧。
Nature. 2021 Jan;589(7841):182. doi: 10.1038/d41586-021-00001-6.
9
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers.一线工作者接种第三剂mRNA疫苗对SARS-CoV-2变异株的防护作用
N Engl J Med. 2022 May 12;386(19):1855-1857. doi: 10.1056/NEJMc2201821. Epub 2022 Apr 6.
10
Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.循环中的新冠病毒变异株的中和敏感性。
N Engl J Med. 2021 Jun 17;384(24):2354-2356. doi: 10.1056/NEJMc2103022. Epub 2021 Apr 6.
引用本文的文献
1
Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives.纳米医学的治疗应用：最新进展和未来展望。
Molecules. 2024 Apr 30;29(9):2073. doi: 10.3390/molecules29092073.
2
Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications.关于膜联蛋白 A2 在 COVID-19 发病机制和感染后并发症中可能作用的分子见解。
Int J Mol Sci. 2021 Oct 13;22(20):11028. doi: 10.3390/ijms222011028.
3
Comparison of Different Waves during the COVID-19 Pandemic: Retrospective Descriptive Study in Thailand.新冠疫情期间不同波次的比较：泰国的回顾性描述性研究
Adv Prev Med. 2021 Oct 8;2021:5807056. doi: 10.1155/2021/5807056. eCollection 2021.
4
SARS-CoV-2 vaccination efficacy on hospitalisation and variants.SARS-CoV-2 疫苗对住院和变异的疗效。
Anaesth Crit Care Pain Med. 2021 Jun;40(3):100874. doi: 10.1016/j.accpm.2021.100874. Epub 2021 May 1.
5
SARS-CoV-2 vaccination efficacy on hospitalisation and variants.严重急性呼吸综合征冠状病毒2型疫苗对住院治疗及病毒变体的有效性
Anaesth Crit Care Pain Med. 2021 Apr 23:100867. doi: 10.1016/j.accpm.2021.100867.
本文引用的文献
1
Are Some COVID-19 Vaccines Better Than Others? Interpreting and Comparing Estimates of Efficacy in Vaccine Trials.某些新冠疫苗比其他疫苗更好吗？解读和比较疫苗试验中的疗效评估。
Clin Infect Dis. 2022 Jan 29;74(2):352-358. doi: 10.1093/cid/ciab213.
2
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.202012/1 感染关注的 SARS-CoV-2 变异株的患者的死亡率风险：匹配队列研究。
BMJ. 2021 Mar 9;372:n579. doi: 10.1136/bmj.n579.
3
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.在英格兰，估计 SARS-CoV-2 谱系 B.1.1.7 的传染性和影响。
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.abg3055. Epub 2021 Mar 3.
4
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.南非新冠病毒 501Y.V2 变异株可逃避南非捐赠者血浆的中和作用。
Nat Med. 2021 Apr;27(4):622-625. doi: 10.1038/s41591-021-01285-x. Epub 2021 Mar 2.
5
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.BNT162b2 mRNA 新冠病毒疫苗在全国大规模疫苗接种环境中的效果。
N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24.
6
SARS-CoV-2 variants and ending the COVID-19 pandemic.严重急性呼吸综合征冠状病毒2变体与终结2019冠状病毒病大流行
Lancet. 2021 Mar 13;397(10278):952-954. doi: 10.1016/S0140-6736(21)00370-6. Epub 2021 Feb 11.
7
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.mRNA 疫苗诱导的针对 SARS-CoV-2 和循环变异株的抗体。
Nature. 2021 Apr;592(7855):616-622. doi: 10.1038/s41586-021-03324-6. Epub 2021 Feb 10.
8
Vaccines are curbing COVID: Data from Israel show drop in infections.疫苗正在遏制新冠疫情：以色列的数据显示感染人数下降。
Nature. 2021 Feb;590(7845):197. doi: 10.1038/d41586-021-00316-4.
9
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.BNT162b2 疫苗诱导的人血清对 SARS-CoV-2 谱系 B.1.1.7 假病毒的中和作用。
Science. 2021 Mar 12;371(6534):1152-1153. doi: 10.1126/science.abg6105. Epub 2021 Jan 29.
10
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
Zotero 插件